BioMarin Pharmaceutical Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (31)

Latest Posts

About This Stock More About This Stock
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
Article By: T.J. Hayes
Monday, September 9, 2019 7:36 PM EDT
The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.
In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB
Read
3 Biotech Stocks Up In The Past Month On Industry Turnaround
Article By: Zacks Investment Research
Tuesday, June 5, 2018 1:08 PM EDT
After a strong start in 2018, the drug sector struggled a bit in the next few months probably on U.S. market instability and a few negative updates on the pipeline and regulatory front.
In this article: BMRN, LGND, VVUS Also: JNJ
Read
Healthcare Investing Ideas Big And Small
Article By: Marc Lichtenfeld
Monday, January 15, 2018 9:00 PM EDT
With a dire need for growth, many in the industry expect the larger biotech and pharmaceutical companies to open their wallets and acquire smaller companies with novel drugs in development.
In this article: BMY, GSK, JNJ, PFE, AVXL, IMMP, BMRN, FOLD, SGEN, MBOT
Read
XBI Breaks Through On A Strong Week For Biotech
Article By: Rod Raynovich
Friday, September 29, 2017 7:25 PM EDT
The XBI is up 3.17% this week, 46% YTD, compared to only 1.1% WTD for the IBB. The breakthrough gains for the XBI can be attributed to strong performance of top ten holdings that are primarily mid-caps and M&A prospects.
In this article: BMY, ALNY, BMRN, IBB, AMGN, CELG, CLVS, XBI, JUNO, PBYI, SRPT, BLUE, PTCT, ABBV, FMI
Read
Reading The Tape Of Biomarin Pharma
Video By: readtheticker
Friday, September 15, 2017 11:34 AM EDT
Biotechs are recovering and Biomarin Pharma's stock is lagging, but getting ready to move.
In this video: BMRN
Watch

PARTNER HEADLINES

Latest Tweets for $BMRN

No tweets yet!